(Q73134927)

English

Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up

scientific article published on 01 November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

based on heuristic

inferred from title

Hormone Replacement Therapy

1 reference

based on heuristic

inferred from title

author name string

S J Pierce

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M R Gazvani

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R G Farquharson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

74

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

964-968

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Gonadotropin-releasing hormone agonists and the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Nafarelin therapy in endometriosis: long-term effects on bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Increased bone turnover during gonadotropin-releasing hormone superagonist-induced ovulation inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

The effects of nafarelin and danazol on vertebral trabecular bone mass in patients with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Reduced bone mass in reproductive-aged women with endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Interval bone mineral density with long-term gonadotropin-releasing hormone agonist suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901537-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(00)01537-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11056241%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73134927&oldid=1806544656"